Literature DB >> 14501845

An update on electrophysiological studies in neuropathy.

Christian Krarup1.   

Abstract

PURPOSE OF REVIEW: The review concentrates on the use of clinical neurophysiology in peripheral nerve disorders covered in the present issue. It is pertinent to distinguish different types of involvement of fibers in diabetic neuropathy, including the involvement of small and large fibers, to outline the diagnostic criteria of inflammatory neuropathies, and to describe the spectrum of peripheral nerve pathophysiology in inherited neuropathies. Painful neuropathies represent a particular challenge to clinical neurophysiology since it is mainly small fibers, which are difficult to study, that are affected. RECENT
FINDINGS: Electrodiagnostic studies have relevance in distinguishing neuropathies with different etiologies in diabetes mellitus, and different strategies and methods are necessary to study patients with autonomic and small-fiber involvement. The involvement of motor or sensory fibers, or both, and primary axonal or demyelinative pathology are important questions relating to immune-mediated neuropathies studied in the context of the specificity of antibodies against various neuronal and Schwann-cell structures. In hereditary neuropathy, electrophysiological studies are also used to distinguish axonal neuropathies from demyelinating neuropathies, though overlap and 'intermediate' patterns have become well recognized. In pain syndromes, conventional electrophysiological studies may give normal results if large fibers are not involved, and the use of autonomic measures in these situations has particular relevance.
SUMMARY: The usefulness of electrodiagnostic measures depends on the clinical, diagnostic, or pathophysiological question involved, and the strategy employed should reflect the advantages and limitations of these methods. If adequate consideration is paid to these properties, then such studies have a central role in the diagnosis and adequate treatment of patients with neuromuscular disorders.

Entities:  

Mesh:

Year:  2003        PMID: 14501845     DOI: 10.1097/01.wco.0000093104.34793.94

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  12 in total

1.  The sural sensory/radial motor amplitude ratio for the diagnosis of peripheral neuropathy in type 2 diabetic patients.

Authors:  N Papanas; G Trypsianis; G Giassakis; K Vadikolias; D Christakidis; H Piperidou; G Efstratiadis; E Maltezos
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

2.  Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.

Authors:  Gaia Cermenati; Federico Abbiati; Solei Cermenati; Elisabetta Brioschi; Alessandro Volonterio; Guido Cavaletti; Enrique Saez; Emma De Fabiani; Maurizio Crestani; Luis M Garcia-Segura; Roberto C Melcangi; Donatella Caruso; Nico Mitro
Journal:  J Lipid Res       Date:  2011-12-07       Impact factor: 5.922

3.  Comparative Pre-Emptive Analgesic Efficacy Study of Novel Antiepileptic Agents Lamotrigine and Topiramate in Patients Undergoing Major Surgeries at a Tertiary Care Hospital: A Randomized Double Blind Clinical Trial.

Authors:  Ankush Gupta; Uma A Bhosale; Priyank Shah; Radha Yegnanarayan; Shalini Sardesai
Journal:  Ann Neurosci       Date:  2016-09-09

4.  Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes.

Authors:  H-J Kabitz; F Sonntag; D Walker; A Schwoerer; S Walterspacher; S Kaufmann; F Beuschlein; J Seufert; W Windisch
Journal:  Diabetologia       Date:  2007-11-22       Impact factor: 10.122

5.  Differential role of N-type calcium channel splice isoforms in pain.

Authors:  Christophe Altier; Camila S Dale; Alexandra E Kisilevsky; Kevin Chapman; Andrew J Castiglioni; Elizabeth A Matthews; Rhian M Evans; Anthony H Dickenson; Diane Lipscombe; Nathalie Vergnolle; Gerald W Zamponi
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

Review 6.  Role of voltage-gated calcium channels in ascending pain pathways.

Authors:  Gerald W Zamponi; Richard J Lewis; Slobodan M Todorovic; Stephen P Arneric; Terrance P Snutch
Journal:  Brain Res Rev       Date:  2008-12-31

Review 7.  The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.

Authors:  Vera Bril; Christopher M Blanchette; Joshua M Noone; M Chris Runken; Deborah Gelinas; James W Russell
Journal:  J Diabetes Complications       Date:  2016-05-10       Impact factor: 2.852

Review 8.  Venom peptides as a rich source of cav2.2 channel blockers.

Authors:  Silmara R Sousa; Irina Vetter; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

Review 9.  Omega-conotoxins as experimental tools and therapeutics in pain management.

Authors:  Heidi E Hannon; William D Atchison
Journal:  Mar Drugs       Date:  2013-03-07       Impact factor: 5.118

10.  Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes.

Authors:  Xiaona Qiao; Shuo Zhang; Weiwei Zhao; Hongying Ye; Yehong Yang; Zhaoyun Zhang; Qing Miao; Renming Hu; Yiming Li; Bin Lu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.